Annual ROE
-507.47%
-365.00%-256.19%
December 31, 2024
Summary
- As of March 13, 2025, APVO annual return on equity is -507.47%, with the most recent change of -365.00% (-256.19%) on December 31, 2024.
- During the last 3 years, APVO annual ROE has fallen by -187.91% (-58.80%).
- APVO annual ROE is now -706.59% below its all-time high of 83.66%, reached on December 31, 2022.
Performance
APVO ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-488.93%
-140.18%-40.19%
December 31, 2024
Summary
- As of March 13, 2025, APVO quarterly return on equity is -488.93%, with the most recent change of -140.18% (-40.19%) on December 31, 2024.
- Over the past year, APVO quarterly ROE has dropped by -384.11% (-366.45%).
- APVO quarterly ROE is now -545.45% below its all-time high of 109.76%, reached on June 30, 2022.
Performance
APVO Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
APVO ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -256.2% | -366.4% |
| 3 y3 years | -58.8% | -366.4% |
| 5 y5 years | -165.0% | -366.4% |
APVO ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -706.6% | at low | -545.5% | +8.6% |
| 5 y | 5-year | -706.6% | at low | -545.5% | +8.6% |
| alltime | all time | -706.6% | at low | -545.5% | +8.6% |
Aptevo Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | -507.47%(+256.2%) | -488.93%(+40.2%) |
| Sep 2024 | - | -348.75%(+31.0%) |
| Jun 2024 | - | -266.14%(+21.4%) |
| Mar 2024 | - | -219.24%(+109.2%) |
| Dec 2023 | -142.47%(-270.3%) | -104.82%(+17.1%) |
| Sep 2023 | - | -89.48%(-6.2%) |
| Jun 2023 | - | -95.36%(-203.2%) |
| Mar 2023 | - | 92.44%(+46.5%) |
| Dec 2022 | 83.66%(-126.2%) | 63.08%(-15.8%) |
| Sep 2022 | - | 74.95%(-31.7%) |
| Jun 2022 | - | 109.76%(-120.5%) |
| Mar 2022 | - | -534.97%(+86.1%) |
| Dec 2021 | -319.56%(+156.0%) | -287.52%(-0.7%) |
| Sep 2021 | - | -289.64%(+3.4%) |
| Jun 2021 | - | -280.06%(+6.6%) |
| Mar 2021 | - | -262.73%(+61.2%) |
| Dec 2020 | -124.84% | -163.02%(-0.5%) |
| Sep 2020 | - | -163.84%(+40.7%) |
| Jun 2020 | - | -116.46%(+2.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | -113.92%(-28.3%) |
| Dec 2019 | -191.48%(+100.5%) | -158.84%(+9.2%) |
| Sep 2019 | - | -145.48%(+9.5%) |
| Jun 2019 | - | -132.91%(+22.0%) |
| Mar 2019 | - | -108.96%(+14.0%) |
| Dec 2018 | -95.50%(-1007.8%) | -95.59%(+32.1%) |
| Sep 2018 | - | -72.37%(-4651.6%) |
| Jun 2018 | - | 1.59%(-63.3%) |
| Mar 2018 | - | 4.33%(-58.3%) |
| Dec 2017 | 10.52%(-106.5%) | 10.38%(+269.4%) |
| Sep 2017 | - | 2.81%(-101.7%) |
| Jun 2017 | - | -166.18%(+19.0%) |
| Mar 2017 | - | -139.69%(+4.1%) |
| Dec 2016 | -161.53%(+149.5%) | -134.15%(+7.1%) |
| Sep 2016 | - | -125.26%(+125.9%) |
| Jun 2016 | - | -55.44%(-6.0%) |
| Mar 2016 | - | -58.98%(-11.9%) |
| Dec 2015 | -64.75%(+19.8%) | -66.93% |
| Dec 2014 | -54.03% | - |
FAQ
- What is Aptevo Therapeutics annual return on equity?
- What is the all time high annual ROE for Aptevo Therapeutics?
- What is Aptevo Therapeutics annual ROE year-on-year change?
- What is Aptevo Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Aptevo Therapeutics?
- What is Aptevo Therapeutics quarterly ROE year-on-year change?
What is Aptevo Therapeutics annual return on equity?
The current annual ROE of APVO is -507.47%
What is the all time high annual ROE for Aptevo Therapeutics?
Aptevo Therapeutics all-time high annual return on equity is 83.66%
What is Aptevo Therapeutics annual ROE year-on-year change?
Over the past year, APVO annual return on equity has changed by -365.00% (-256.19%)
What is Aptevo Therapeutics quarterly return on equity?
The current quarterly ROE of APVO is -488.93%
What is the all time high quarterly ROE for Aptevo Therapeutics?
Aptevo Therapeutics all-time high quarterly return on equity is 109.76%
What is Aptevo Therapeutics quarterly ROE year-on-year change?
Over the past year, APVO quarterly return on equity has changed by -384.11% (-366.45%)